Last reviewed · How we verify
Allergen extract
At a glance
| Generic name | Allergen extract |
|---|---|
| Also known as | Ragwitek, Grastek |
| Sponsor | Roxall Medizin |
| Modality | Biologic |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Resolution of Allergic Inflammation (NA)
- Allergenic Extract Standardized Cat Hair AP in an Allergic Rhinitis Model. (NA)
- Efficacy and Safety of SLIT in Patients With Rhinitis/RC With/Without Mild-moderate Asthma, Due to Dpt and/or Df (PHASE3)
- Evaluation of the Efficacy and Safety of an Intensified Strategy of Intratonsillar Immunotherapy (ITIT) for Allergic Rhinitis: A Multicenter, Randomized, Double-blind, Controlled Trial (NA)
- Determination of Blomia Tropicalis Allergen Extract in Prick Test Units (NA)
- Phleum Pratense and Dactylis Glomerata Allergen Extracts Standardization (NA)
- Pilot Study to Identify the Mediators and Inflammatory Cell Surface Receptors Involved in Allergic Airway Inflammation (PHASE1)
- Dietary Supplement (Beta-Glucans) in Allergic Patients Undergoing Subcutaneous Immunotherapy. (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Allergen extract CI brief — competitive landscape report
- Allergen extract updates RSS · CI watch RSS
- Roxall Medizin portfolio CI